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It is no news that many human diseases have a genetic cause.
Indeed, it is often said that you can have ‘the cystic ﬁbrosis
gene’ or ‘the breast cancer gene’. What is meant, of course, is
thatweallhavethatgenebutthatpeoplewiththediseasehave
avariant of the gene, which can cause the disease. So far, more
than 50000 disease-causing alleles, involving 1900 protein-
coding genes and 2000 human disorders have been identiﬁed
(Stenson et al, 2003). Little is known, however, about the
relationships between different types of gene mutations, how
they affect the corresponding proteins at a systems level, and
how this relates to the manifestation of human disease.
Two broad categories of gene mutations can be considered:
‘truncating alleles’ that can produce a protein fragment, and
‘in-frame alleles’ that produce a full-length protein with a
seemingly minor change in one or more amino acids. Some
proteins interact with many different partners to accomplish
oneparticulartask.Otherproteinscanhavedifferentfunctions
at different locations or under different conditions. Such
moonlightingprobablyoccursdue to speciﬁcinteractionswith
different partner proteins that facilitate or prevent particular
functionalities in different places or at different times. Finally,
there are different manifestations of human disease: some are
autosomal dominant with only one copy of the relevant gene
affected, whereas others are autosomal recessive with both
gene copies mutated.
In a recent article published in Molecular Systems Biology
(Zhong et al, 2009), Marc Vidal and colleagues connect some
of the dots between these different features by considering
diseases and the mutations that cause them in the context of
‘interactome’ networks. Such networks are composed of
proteins (nodes) and the physical interactions between them
(edges). Previously, it had been observed in C. elegans that
genetically identiﬁed mutations can affect a speciﬁc set of
interactions while leaving others intact (Walhout et al, 2000).
Such mutations are referred to as ‘interaction defective alleles’
(Figure 1). In the new study, this ﬁnding is extended to human
interactome networks. The ﬁrst observation presented is that
disorders caused by in-frame alleles are often autosomal
dominant: more than 20% of all autosomal dominant
disorders are solely caused by in-frame alleles, whereas this
is true for only B2% of autosomal recessive disorders. Even
thoughtheeffectobservedissmallandwasrevealedbycareful
data binning, it nicely suggests that there is a correlation
between disease manifestation and different types of mutant
alleles.
The authors then used an elegant interactome pipeline that
is based on yeast two-hybrid (Y2H) assays. Five proteins
associated with genetic disorders were selected and the
interactions of the wild-type alleles with their partners were
compared to the patterns of interactions observed with several
of the respective disease-causing alleles. From the analysis of
29 alleles, three different interaction proﬁles were obtained:
(1) loss of all Y2H interactions (‘null’ alleles), (2) loss of none
of the known Y2H interactions (‘pseudo-wild-type’ alleles), or
(3)loss ofsome,butnotallY2Hinteractions (‘edgetic’alleles).
These results provide further support for the notion that
different interaction defective alleles result from particular
disease-related mutations. As expected, mutated residues are
morelikelytobeburiedintheproteinwhenallinteractionsare
affected, which is likelybecause the proteinhas been rendered
unstable. Conversely, edgetic mutations are more frequently
surface exposed. Interestingly, however, again a correlation
was observed: autosomal dominant diseases are more
frequentlyassociated with in-frame alleles that affect a surface
exposed residue than autosomal recessive diseases. The
authors then compared 142 genes that are associated with
two or more diseases and for which at least ﬁve alleles are
known.Theyfoundmanygenesforwhichtheproportionofin-
frame versus truncating alleles is signiﬁcantly different
between the diseases they cause. For 34 genes that are linked
to both dominant and recessive disorders the fraction of in-
frame alleles is again higher for autosomal dominant muta-
tions. Finally, they found that genes that are involved in
multiple diseases and that encode proteins with multiple
domains carry mutations in different domains for different
diseases, further strengthening the notion that edgetic alleles
may lie at the heart of numerous human diseases.
Although the study nicely broadens our view of human
genetic disease and provides an important network context,
manyquestionsremainopen.Forexample,itwillbeimportant
to determine which of the affected edges are actually causal to
the disease. Furthermore, dominance might be explained by
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gain of interactions would provide a more parsimonious
explanation of dominance than interaction loss. Different
alleles could confer new interactions with different proteins
that result in different phenotypes. When an edge is lost it is
moredifﬁculttoexplainhowthatgenerallyaffectsthefunction
of the remaining wild type protein. It could be that, as the
authors suggest, the affected protein alters a larger complex,
but then how does loss of interactions with different partners
give different disease phenotypes? Another potential mechan-
ism is that mutation in protein X, results in loss of an
interaction with protein Yand that this ‘freed up’ protein Y is
actually causing the disease, even though that protein is itself
not mutated.
Longer term, it will be interesting to extend the concept of
‘edgetic’ allele to networks of genetic interactions in order to
further understand both single Mendelian disorders and
complex multi-genic diseases. In addition, including other
types of physical interactions in the analysis such as those
betweenproteinsandDNAwillbeimportanttounderstandthe
impact of non-coding disease-causing mutations that may
affect interactions with a DNA binding protein or to study
transcription factor alleles. In this context, yeast one-hybrid,
rather than Y2H assays, will provide a facile tool to
experimentally investigate changes in protein-DNA interac-
tions (Deplancke et al, 2006). Future interactome studies that
gobeyondtheaffectednodesanditsimmediateneighbors,and
that include different types of interactions will provide a fertile
ground to reveal how subtle network perturbations cause or
modulate human disease.
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Figure 1 Node and edge perturbations by disease-causing mutations. A
protein (red dot) performs its function via physical interactions (black edges) with
other partner proteins (A). A ‘null’ allele results in the complete removal of the
protein and thus the loss of all interactions (B). In contrast, ‘interaction defective
alleles’or‘edgetic’alleles(indicatedbyanasterisk)altertheproﬁleofinteractions
by affecting a speciﬁc subset of edges in the interactome (C). Distinct network
perturbations by edgetic and null alleles may cause different genetic diseases.
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